Seres Therapeutics (MCRB) Ownership - Who Owns Seres Therapeutics?

1,084 Followers

Seres Therapeutics (MCRB) Ownership Overview

1.16% Insiders

4.20% Mutual Funds

12.28% Other Institutional Investors

4.30% ETFs

78.07% Public Companies and

Individual Investors

The ownership structure of Seres Therapeutics (MCRB) stock is a mix of institutional, retail, and individual investors. Approximately 20.78% of the company’s stock is owned by Institutional Investors, 1.16% is owned by Insiders, and 78.07% is owned by Public Companies and Individual Investors.

The ownership structure of Seres Therapeutics (MCRB) stock is a mix of institutional, retail, and individual investors. Approximately 16.47% of the company’s stock is owned by Institutional Investors, 1.16% is owned by Insiders, and 4.30% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Noubar Afeyan	1,155,850	Institution	11.94%	9,154,332
	276,116	Institution	2.85%	2,186,839
	276,116	Institution	2.85%	2,186,839
	63,492	Insider	0.66%	502,857
	58,550	Institution	0.60%	463,716
	48,542	Institution	0.50%	384,453
	33,558	Institution	0.35%	265,779
	31,505	Institution	0.33%	249,520
	16,639	Institution	0.17%	131,781
	14,500	Institution	0.15%	114,840

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
276,116	Institution	2.85%	2,186,839
58,550	Institution	0.60%	463,716
33,558	Institution	0.35%	265,779
11,153	Institution	0.12%	88,332
8,400	Institution	0.09%	66,528
7,500	Institution	0.08%	59,400
3,498	Institution	0.04%	27,704
2,982	Institution	0.03%	23,617
2,532	Institution	0.03%	20,053
1,176	Institution	0.01%	9,314

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	206,170	Institution	2.13%	1,828,728
Vanguard Extended Market ETF	69,946	Institution	0.72%	620,421
Avantis U.S. Small Cap Value ETF	42,243	Institution	0.44%	336,254
Schwab U.S. Small-Cap ETF	31,505	Institution	0.33%	246,999
Black Diamond Distressed Opportunities Fund Trust Units	22,472	Institution	0.23%	172,203
iShares Micro-Cap ETF	16,639	Institution	0.17%	132,446
Invesco FTSE RAFI US 1500 Small-Mid ETF	14,496	Institution	0.15%	115,388
U.S. Micro Cap Portfolio ETF	7,662	Institution	0.08%	66,966
WisdomTree U.S. SmallCap Fund	7,157	Institution	0.07%	56,970
Avantis U.S Small Cap Equity ETF	5,277	Institution	0.05%	42,005

FAQ

Who Owns Seres Therapeutics Inc. (MCRB)?

According to the latest TipRanks data, approximately 12.28% of the company's stock is held by institutional investors, 1.16% is held by insiders, and 78.07% is held by retail investors.

What percentage of Seres Therapeutics Inc. (MCRB) stock is held by institutional investors?

According to the latest TipRanks data, approximately 12.28% of Seres Therapeutics Inc. (MCRB) stock is held by institutional investors.

What percentage of Seres Therapeutics Inc. (MCRB) stock is held by retail investors?

According to the latest TipRanks data, approximately 78.07% of Seres Therapeutics Inc. (MCRB) stock is held by retail investors.

Who owns the most shares of Seres Therapeutics Inc. (MCRB)?

Noubar Afeyan owns the most shares of Seres Therapeutics Inc. (MCRB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.